Product Information
QNASL 80 MCG NASAL SPRAY is a brand product labeled by Teva Respiratory, LLC, priced at $30.2255 per GM under NDC 59310041012. Its NADAC has been published 394 times since Mar 20, 2019.
FDA first approved this application on Mar 23, 2012.
Strength
80 ug/1
Manufacturer
Teva Respiratory, LLCNDC
59310041012
Classification
Brand
Dosage Form
AEROSOL, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
BECLOMETHASONE DIPROPIONATEApproval Type
New Drug (NDA)
FDA Application
NDA202813FDA Approved
3/23/2012
On Market Since
1/2/2019
Pharmacological Classes
Price Statistics
The NADAC for QNASL 80 MCG NASAL SPRAY has been published 394 times since Mar 20, 2019, and over the history we have for it it has risen 46.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $30.2255 per GM |
|---|---|
| All-time high | $30.3145 (May 13, 2026) |
| All-time low | $20.6735 (Mar 20, 2019) |
| 52-week high | $30.3145 |
| 52-week low | $28.8685 |
| Median price | $25.4535 |
| Average price | $25.5763 |
| Largest weekly change | +9.4% (Jan 12, 2022) |
| Weeks tracked | 394 |
| Tracking since | Mar 20, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Beclomethasone dipropionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Respiratory, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Beclomethasone dipropionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QNASL 80 MCG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for QNASL 80 MCG NASAL SPRAY, manufactured by Teva Respiratory, LLC, is $30.2255 per GM (NDC 59310041012), effective Sep 30, 2026.
How has the price of QNASL 80 MCG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for QNASL 80 MCG NASAL SPRAY has risen 46.2%. It has been tracked across 394 weekly CMS publications since Mar 20, 2019.
What are the highest and lowest recorded NADAC prices for QNASL 80 MCG NASAL SPRAY?
Since Mar 20, 2019, the NADAC for QNASL 80 MCG NASAL SPRAY has ranged from a low of $20.6735 (Mar 20, 2019) to a high of $30.3145 (May 13, 2026), with a median of $25.4535 per GM.
Are there cheaper alternatives to QNASL 80 MCG NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of QNASL 80 MCG NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QNASL 80 MCG NASAL SPRAY?
QNASL 80 MCG NASAL SPRAY (NDC 59310041012) is labeled by Teva Respiratory, LLC, and CMS classifies it as a brand product.